In late September, the FDA submitted guidelines on its process for emergency approval of the coronavirus vaccines to the White House. For over two weeks, they waited for a sign-off. The holdup was Mark Meadows. He was concerned there were too many unnecessary steps in the FDA authorization process. It would take too long.
